When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials

医学 斑秃 头皮 内科学 随机对照试验 脱发 临床试验 胃肠病学 皮肤病科
作者
Brett King,Jerry Shapiro,Manabu Ohyama,Alexander Egeberg,Bianca Maria Piraccini,Brittany G. Craiglow,Rodney Sinclair,Yun-Fei Chen,Wen-Shuo Wu,Yuxin Ding,Najwa Somani,Yves Dutronc
出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:189 (6): 666-673 被引量:18
标识
DOI:10.1093/bjd/ljad253
摘要

Abstract Background Baricitinib is approved for the treatment of adults with severe alopecia areata (AA). In the absence of robust data on the patterns of regrowth during treatment of severe AA, there is a gap in the knowledge regarding treatment expectations. Objectives To examine whether different clinical response subgroups could be identified in baricitinib-treated patients with severe AA and factors that contribute to these subgroups. Methods The BRAVE-AA1 and BRAVE-AA2 phase III trials enrolled patients with severe AA [Severity of Alopecia Tool (SALT) score ≥ 50 (≥ 50% scalp hair loss)]. Patients randomized to baricitinib 4 mg or 2 mg retained their treatment allocation for 52 weeks. Based on patterns identified through growth mixture modelling (GMM), patients were categorized into responder subgroups according to when they first achieved ≥ 30% improvement from baseline in SALT score (SALT30). For each responder subgroup, trajectories of response (i.e. achievement of a SALT score ≤ 20, SALT score ≤ 10 and ≥ 50% change from baseline in SALT score) and baseline disease characteristics are reported. Results Respectively, 515 and 340 patients were randomized to once-daily baricitinib 4 mg and 2 mg at baseline; 69% and 51%, respectively, achieved SALT30 at least once by week 52. Based on GMM findings, we identified three responder subgroups: early (SALT30 by week 12), gradual (SALT30 after week 12–week 36) and late (SALT30 after week 36–week 52). The proportions of early, gradual and late responders and nonresponders were, respectively, 33%, 28%, 8% and 31% among patients treated with baricitinib 4 mg, and 20%, 23%, 9% and 49%, respectively, among those treated with baricitinib 2 mg. Early responders had a shorter trajectory to maximal clinical outcomes (e.g. > 78% achieved a SALT score ≤ 20 by week 36) vs. gradual or late responders. Early responders were more frequent among patients with baseline severe AA (SALT score 50 to < 95) vs. very severe AA (SALT score 95–100). Overall, responders (early to late) were more frequent in patients with short (< 4 years) episodes of hair loss. Conclusions These analyses identified early, gradual and late responder subgroups for scalp hair regrowth in baricitinib-treated patients with severe AA, and that these subgroups are influenced by baseline characteristics. Findings from these analyses will help to inform treatment expectations for scalp hair regrowth.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Z小姐完成签到 ,获得积分10
2秒前
橘子完成签到,获得积分10
2秒前
笙笙的应助被liu采纳,获得20
10秒前
潜龙完成签到 ,获得积分10
11秒前
活力以冬完成签到,获得积分10
12秒前
传奇3的应助被12138采纳,获得10
13秒前
霸气糜完成签到,获得积分10
15秒前
15秒前
睡不醒完成签到 ,获得积分10
16秒前
追寻书本完成签到,获得积分10
18秒前
碧绿的雪莲完成签到 ,获得积分10
19秒前
鲁卓林完成签到,获得积分10
20秒前
dingyi发布了新的文献求助10
21秒前
小白白完成签到 ,获得积分10
22秒前
迅速的念芹完成签到 ,获得积分10
25秒前
27秒前
蓝莓芝士完成签到 ,获得积分10
27秒前
liu完成签到,获得积分10
28秒前
浊酒发布了新的文献求助10
33秒前
SciEngineerX完成签到,获得积分0
37秒前
自由的M完成签到 ,获得积分10
37秒前
yang完成签到 ,获得积分0
42秒前
kyousan完成签到,获得积分10
45秒前
Liii完成签到 ,获得积分10
46秒前
leapper发布了新的文献求助10
49秒前
柒川森完成签到 ,获得积分10
52秒前
霸气的小土豆完成签到 ,获得积分10
56秒前
1分钟前
n01W97的应助被leapper采纳,获得10
1分钟前
goodsheperd完成签到 ,获得积分10
1分钟前
planto完成签到,获得积分0
1分钟前
着急的靖柔完成签到,获得积分10
1分钟前
Rongbid完成签到,获得积分10
1分钟前
清脆代真完成签到,获得积分20
1分钟前
dingyi完成签到,获得积分10
1分钟前
Ken完成签到 ,获得积分10
1分钟前
syvshc的应助被Wang采纳,获得10
1分钟前
遇见完成签到,获得积分10
1分钟前
俏皮的莫言完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173289
求助须知:如何正确求助?哪些是违规求助? 9565594
关于积分的说明 21780581
捐赠科研通 7767462
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697